English   español  

Browsing by Author Ocaña, Alberto

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 73  next >
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessTranscriptomic_Pérez_Peña_Art2019.pdf.jpg18-Dec-2019A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast TumorsPérez-Peña, Javier; Tibor Fekete, Janos; Páez, Raquel; Baliu-Piqué, Mariona; García-Saenz, José Ángel; García-Barberán, Vanesa; Manzano, Aranzazu ; Pérez-Segura, Pedro; Esparís-Ogando, Azucena  ; Pandiella, Atanasio  ; Győrffy, Balázs; Ocaña, Albertoartículo
openAccessMeta-Analysis.pdf.jpg2014Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysisOcaña, Alberto; Cuenca-López, María D.; Seruga, Bostjan; Pandiella, Atanasio  ; Amir, Eitanartículo
closedAccessaccesoRestringido.pdf.jpg2012Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancerMontero, Juan Carlos ; Esparís-Ogando, Azucena  ; Re-Louhau, M. F. ; Seoane, Samuel ; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio  artículo
openAccessactivity_BET-proteolysis_targeting_chimeric.pdf.jpg30-Aug-2019Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancerNoblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos ; Esparís-Ogando, Azucena  ; Pandiella, Atanasio  ; Galán-Moya, Eva María; Ocaña, Albertoartículo
closedAccessaccesoRestringido.pdf.jpg2020Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanismsRíos-Luci, Carla; Díaz-Rodríguez, Elena ; Gandullo-Sánchez, Lucía; Díaz-Gil, Laura; Ocaña, Alberto; Pandiella, Atanasio  artículo
openAccessAdoptive_Fuentes_Art2020.pdf.jpgOct-2020Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation MedicineFuentes-Antrás, Jesús; Guevara-Hoyer, Kissy; Baliu-Piqué, Mariona; García-Saenz, José Ángel; Pérez-Segura, Pedro; Pandiella, Atanasio  ; Ocaña, Albertoartículo de revisión
openAccessOverview_Juan_PV_Art2020.pdf.jpg2020An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer TherapyJuan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio  ; Ocaña, Alberto; Alonso-Moreno, Carlosartículo
openAccessAntibody_Juan_PV_Art2020.pdf.jpg21-Aug-2020Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer TreatmentJuan, Alberto; Cimas, Francisco J.; Bravo, Iván; Pandiella, Atanasio  ; Ocaña, Alberto; Alonso, Carlos artículo
openAccessEC-70124.pdf.jpg2015Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancerCuenca-López, María D.; Serrano-Heras, Gemma ; Montero, Juan Carlos ; Morales, Jorge C.; Pandiella, Atanasio  ; Ocaña, Albertoartículo
openAccessarrest in G2.pdf.jpg2015Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2Pandiella, Atanasio  ; Morís, Francisco; Ocaña, Alberto; Núñez, Luz-Elena; Montero, Juan Carlos artículo
openAccessBETcan.pdf.jpg2017BET inhibitors as novel therapeutic agents in breast cancerOcaña, Alberto; Nieto-Jiménez, Cristina; Pandiella, Atanasio  artículo
closedAccessaccesoRestringido.pdf.jpg2014Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumorsOcaña, Alberto; Freedman, Orit; Amir, Eitan; Seruga, Bostjan; Pandiella, Atanasio  artículo
closedAccessaccesoRestringido.pdf.jpg2016Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling nodeSeoane, Samuel ; Montero, Juan Carlos ; Ocaña, Alberto; Pandiella, Atanasio  artículo
openAccessBreast_Baliu_PV_Art2020.pdf.jpg2020Breast Cancer Heterogeneity and Response to Novel TherapeuticsBaliu-Piqué, Mariona; Pandiella, Atanasio  ; Ocaña, Albertoartículo
closedAccessaccesoRestringido.pdf.jpg2016Circulating DNA and survival in solid tumorsOcaña, Alberto; Díez-González, Laura; García-Olmo, Dolores C.; Templeton, Arnoud J.; Vera-Badillo, Francisco; Escribano, María José; Serrano-Heras, Gemma ; Corrales-Sánchez, Verónica; Seruga, Bostjan; Andrés-Pretel, Fernando; Pandiella, Atanasio  ; Amir, Eitanartículo
openAccessdnacanc.pdf.jpg2017DNA-damage related genes and clinical outcome in hormone receptor positive breast cancerNieto-Jiménez, Cristina; Alcaraz-Sanabria, Ana; Páez, Raquel; Pérez-Peña, Javier; Corrales-Sánchez, Verónica; Pandiella, Atanasio  ; Ocaña, Albertoartículo
openAccessdo we have.pdf.jpg2010Do We Have to Change the Way Targeted Drugs Are Developed?Ocaña, Alberto; Pandiella, Atanasio  artículo
openAccess10.1093-jnci-djq315.pdf.jpg22-Sep-2010Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cellsSeoane, Samuel ; Montero, Juan Carlos ; Ocaña, Alberto; Pandiella, Atanasio  artículo
closedAccessaccesoRestringido.pdf.jpg2019Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 studyOcaña, Alberto; Gil-Martín, Marta; Antolín, Silvia; Atienza, María; Montaño, Álvaro; Ribelles, Nuria; Urruticoechea, Ander; Falcón, Alejandro; Pernas, Sonia; Orlando, Javier; Montero, Juan Carlos ; Escudero, María José; Benito, Sara; Caballero, Rosalía; Carrasco, Eva; Rojo, Federico; Pandiella, Atanasio  ; Ruiz-Borrego, Manuelartículo
openAccesspone.0005565.pdf.jpg15-May-2009Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic targetMontero, Juan Carlos ; Ocaña, Alberto; Abad, María del Mar; Ortiz-Ruiz, María Jesús ; Pandiella, Atanasio  ; Esparís-Ogando, Azucena  artículo